Skip to main content
Retour
Watch Compare

Atea Pharmaceuticals, Inc.

Qualité des données : 83%
AVIR
Nasdaq Manufacturing Chemicals
5,79 €
▼ 0,14 € (-2,36%)
Cap. Boursière: 461,30 M
Prix
5,79 €
Cap. Boursière
461,30 M
Fourchette du Jour
5,77 € — 5,96 €
Fourchette 52 Semaines
2,46 € — 6,45 €
Volume
116 257
Ouverture 5,86 €
Moyenne 50J / 200J
4,97 €
16,51% above
Moyenne 50J / 200J
3,73 €
55,12% above

Quick Summary

Points Clés

Negative free cash flow of -132,03 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-46,56%
Au-dessus de la moyenne du secteur (-53,41%)
ROIC-41,17%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio16,66
Interest CoverageN/A

Valorisation

PE (TTM)
-2,91
En dessous de la moyenne du secteur (-1,48)
P/B Ratio1,46
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -2,9 -1,5
P/B 1,5 1,6
ROE % -46,6 -53,4
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

ETFs Holding This Stock

BRSIX BRSIX
0,41% weight
BRUSX BRUSX
0,11% weight
CSGEX CSGEX
0,08% weight
PSGIX PSGIX
0,08% weight
BDSCX BDSCX
0,04% weight
BDSIX BDSIX
0,04% weight
BDSKX BDSKX
0,04% weight
BDSAX BDSAX
0,04% weight
DLHIX DLHIX
0,04% weight
DLRHX DLRHX
0,04% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -158,35 M
ROE -46,56% ROA -43,11%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -132,03 M
ROIC -41,17% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 16,66
Interest Coverage N/A Asset Turnover N/A
Working Capital 315,96 M Tangible Book Value 315,78 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2,91 Forward P/E N/A
P/B Ratio 1,46 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -28,62%
Market Cap 461,30 M Enterprise Value 383,96 M
Per Share
EPS (Diluted TTM) -1,94 Revenue / Share N/A
FCF / Share -1,66 OCF / Share -1,66
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 83,38%
SBC-Adj. FCF -160,89 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — 351,37 M 351,37 M
Net Income -158,35 M -168,39 M -135,96 M -115,91 M 121,19 M
EPS (Diluted) -1,94 -2,00 -1,63 -1,39 1,37
Gross Profit — — — — —
Operating Income -180,89 M -192,95 M -164,16 M -130,65 M 138,38 M
EBITDA — — — — —
R&D Expenses 148,02 M 144,10 M 114,24 M 81,94 M 167,21 M
SG&A Expenses — — — — —
D&A 416 000,0 416 000,0 416 000,0 260 000,0 29 000,0
Interest Expense — — — — —
Income Tax -6,16 M 925 000,0 1,02 M -3,59 M 17,40 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 315,22 M 464,67 M 594,97 M 666,71 M 772,89 M
Total Liabilities 39,78 M 25,80 M 39,78 M 26,14 M 62,82 M
Shareholders' Equity 275,43 M 438,87 M 555,19 M 640,57 M 710,08 M
Total Debt — — — — —
Cash & Equivalents 95,71 M 64,70 M 143,82 M 188,46 M 764,38 M
Current Assets 310,99 M 462,36 M 590,46 M 660,92 M 772,40 M
Current Liabilities 39,78 M 18,60 M 32,38 M 18,48 M 56,88 M